Keywords: USA, FDA, Takeda, Actos, Actelion, Subpoena, Tracleer marketing, Bladder cancer ris, Diabetes, Pulmonary arterial hypertension

Preliminary safety data relating to bladder cancer risk of Takeda’s Actos under review by US FDA; Actelion subpoenaed over Tracleer marketing

Article | 20 September 2010

Print This

The US Food and Drug Administration says it has begun a safety review of Japanese drug major Takeda Pharmaceutical’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in